Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Shionogi
Company Monitoring Page for Shionogi
latest headlines for company on cafepharma
Obesity: Six trials to watch over the next 12 months
Clinical Trials Arena
Fri, 06/30/23 - 11:45 am
Tags:
obesity
,
clinical trials
,
Novo Nordisk
,
Altimmune
,
Innovent Biologics
,
Pfizer
,
Shionogi
,
Tonix
,
semaglutide
,
oxytocin
,
permvidutide
,
mazdutide
,
danuglipron
Shionogi Buys Qpex Biopharma for $140M, Expands Antimicrobial Pipeline
BioSpace
Mon, 06/26/23 - 08:48 pm
Tags:
Shionogi
,
M&A
,
Qpex Biopharma
,
antimicrobials
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches
,
AbbVie
,
Almirall
,
Apellis Pharmaceuticals
,
Astellas
,
AstraZeneca
,
Biogen
,
CRISPR Therapeutics
,
Daiichi Sankyo
,
Eli Lilly
,
Genmab
,
GSK
,
Iveric Bio
,
Pfizer
,
Roche
,
SAGE Therapeutics
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Vertex Pharmaceuticals
Shionogi starts global Phase II clinical trial of redasemtide
Clinical Trials Arena
Tue, 04/11/23 - 10:00 am
Tags:
Shionogi
,
clinical trials
,
redasemtide
,
stroke
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck
Fierce Pharma
Tue, 11/22/22 - 04:28 pm
Tags:
Shionogi
,
COVID-19
,
antivirals
,
Japan
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial
Fierce Biotech
Fri, 03/4/22 - 09:46 am
Tags:
Shionogi
,
vaccines
,
COVID-19
,
Japan
,
Pfizer
Shionogi files for approval of oral COVID-19 antiviral in Japan, brushing off missed clinical endpoint in race to market
Fierce Biotech
Mon, 02/28/22 - 11:19 am
Tags:
Shionogi
,
Japan
,
antivirals
,
COVID-19
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough
Fierce Biotech
Tue, 09/28/21 - 11:38 pm
Tags:
Shionogi
,
HUV
,
ViiV Healthcare
,
clinical trials
,
chronic cough
,
sivopixant
One year after Fetroja approval, Shionogi expands label to include difficult-to-treat pneumonia
Endpoints
Mon, 09/28/20 - 10:44 pm
Tags:
Fetroja
,
Shionogi
,
hospital-acquired pneumonia
,
ventilator-associated bacterial pneumonia
,
FDA
Biopharma takeovers show quantity, if not quality
EP Vantage
Mon, 07/13/20 - 11:13 am
Tags:
COVID-19
,
pandemic
,
M&A
,
Novo Nordisk
,
Corvidia
,
Gilead Sciences
,
Pionyr
,
Alexion
,
Portola Pharmaceuticals
,
Menarini
,
Stemline Therapeutics
,
Shionogi
,
Tetra Therapeutics
PhII Alzheimer's data looming, Shionogi spending up to $500M on a buyout involving one of the toughest bets in biotech
Endpoints
Tue, 05/26/20 - 12:02 pm
Tags:
Shionogi
,
Alzheimer's disease
,
Tetra Therapeutics
,
M&A
Shionogi boosts Tetra Alzheimer's deal, nabs buyout option
Fierce Biotech
Fri, 03/6/20 - 11:41 pm
Tags:
Shionogi
,
Tetra Therapeutics
,
R&D
,
M&A
Roche's Xofluza may give rise to resistant strains, raising fears of a 'worst case scenario'
Endpoints
Tue, 11/26/19 - 11:39 pm
Tags:
Roche
,
Xofluza
,
Japan
,
Shionogi
,
Flu
,
influenza
After positive panel vote, Shionogi antibiotic scores US approval
Endpoints
Fri, 11/15/19 - 10:50 am
Tags:
Shionogi
,
antibiotics
,
FDA
,
cUTI
,
UTIs
,
Fetroja
Despite worries triggered by imbalance of deaths, Shionogi's antibiotic clears FDA panel vote
Endpoints
Thu, 10/17/19 - 10:28 am
Tags:
Shionogi
,
FDA
,
advisory panels
,
antibiotics
,
cefiderocol
,
UTIs
In-house FDA review flags a suspicious imbalance in deaths as Shionogi hunts an OK for antibiotic
Endpoints
Mon, 10/14/19 - 10:26 am
Tags:
Shionogi
,
FDA
,
advisory panels
,
antibiotics
,
UTIs
,
cefiderocol
Shionogi celebrates antibiotic win in pneumonia just ahead of its date with FDA regulators
Endpoints
Wed, 10/9/19 - 10:39 am
Tags:
Shionogi
,
antibiotics
,
FDA
,
cefiderocol
,
nosocomial pneumonia
Two years following US approval, Japan's Shionogi wins EU green light for opioid constipation drug
Endpoints
Fri, 02/22/19 - 10:17 am
Tags:
Shionogi
,
Europe
,
opioid-induced constipation
,
Symproic
,
Rizmoic
FDA Approves First New Flu Drug in Nearly 20 Years
CP Wire
Wed, 10/24/18 - 01:21 pm
Tags:
FDA
,
Xofluza
,
Flu
,
Shionogi
,
Roche
,
Tamiflu
Pages
1
2
3
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.